Parios Regenerative Sciences, Inc. is a privately held company focused on the growing market of skin and dermis tissue regeneration. Parios plans to offer minimally-invasive treatments that are inspired by natural repairing mechanisms. The company is preparing for early R&D work on its Oderm product line. Oderm injectable and topical formulations are derived from organic nanomolecules that self-assemble into structures resembling collagen – the particle responsible for skin’s youthful appearance. Oderm will work with surrounding tissue to restore proper form and function to one’s skin.